PUBLICATIONS
Maritschnegg E, Wang Y, Pecha N, Horvat R, Van Nieuwenhuysen E, Vergote I, Heitz F, Sehouli J, Kinde I, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Speiser P, Zeillinger R.
Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas:
A Proof-of-Concept Study.
Journal of Clinical Oncology 2015 Dec 20;33(36):4293-300.
Medical University of Vienna, Vienna, Austria:
Elisabeth Maritschnegg, Nina Pecha, Reinhard Horvat, Paul Speiser, and Robert Zeillinger
Johns Hopkins University, Baltimore, USA:
Yuxuan Wang, Isaac Kinde, Luis A. Diaz Jr, Nickolas Papadopoulos, Kenneth W. Kinzler and Bert Vogelstein
Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium:
Els Van Nieuwenhuysen and Ignace Vergote,
Kliniken Essen Mitte, Essen, Germany:
Florian Heitz
Charité Medical University, Berlin, Germany:
Jalid Sehouli
Elisabeth Maritschnegg, PhD(a), Dr. Florian Heitz(b), Dr. Nina Pecha(a), Prof. Jirí Bouda(c), PD Dr. Fabian Trillschd(e), Ass.-Prof. Dr. Christoph Grimm(a), Dr. Adriaan Vanderstichele(f), Christiane Agreiter, MSc(a), PD Dr. Philipp Harter(b), Dr. Eva Obermayr(a), Prof. Ignace Vergote(f) Robert Zeillinger(a), Paul Speiser(a)
Lavage of the uterine cavity and fallopian tubes for earlier ovarian cancer detection:
a feasibility and safety study
International Journal of Gynecological Cancer: October 27, 2018 - Volume Publish Ahead of Print
(a) Department of Obstetrics and Gynecology, Medical University of Vienna, Molecular Oncology Group, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria
(b) Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte, Heinrichstrasse 92, 45136 Essen, Germany
(c) Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic
(d) Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
(e) Department of Obstetrics and Gynaecology, University Hospital, LMU Munich, Marchioninistr 15, Munich 81377, Germany
(f) Department of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals
Leuven, KU, Leuven, Leuven, Belgium
Jesse J. Salk(1,2), Kaitlyn Loubet-Senear(3), Elisabeth Maritschnegg(4), Charles C. Valentine(2), Lindsey N. Williams(2) Reinhard Horvat(5), Adriaan Vanderstichele(6), Daniela Nachmanson(3), Kathryn Baker(3), Mary Emond(7), Emily Loter(8), Thierry Soussi(9,10,11), Lawrence A. Loeb(3), Robert Zeillinger(4), Paul Speiser(4) and Rosa Ana Risques(3)*
Ultra-sensitive sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan
(1) Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA. Science Translational Medicine 2018, submitted
(2) TwinStrand Biosciences, Seattle, WA 98121, USA.
(3) Department of Pathology, University of Washington, Seattle, WA 98195, USA.
(4) Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center – Gynecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
(5) Department Pathology, Medical University of Vienna, Vienna, Austria.
(6) Department of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU, Leuven, Belgium.
(7) Department of Statistics, University of Washington, Seattle, WA 98195, USA.
(8) Department of Pathology, Seattle Children’s Hospital, Seattle, WA 98105, USA.
(9) Sorbonne Université, UPMC Univ Paris 06, F- 75005 Paris, France.
(10) Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
(11) INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France.